SCHEMBL6026074

SCHEMBL6026074

COc1ccc(-c2ccc(C3(C)OC(=O)C(O)=C3O)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
HPGD P15428 2/20 0.46
ME2 P23368 1/20 0.45
ME1 P48163 1/20 0.45
ME3 Q16798 1/20 0.45
HDAC4 P56524 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
ESR2 Q92731 1/20 0.43
EDNRA P25101 5/20 0.43
EDNRB P24530 2/20 0.43
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983353 0.84 CHRNA1 (0.42) KDM4EHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL7984718 0.84 CHRNA1 (0.42) KDM4EHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL6026628 0.83 MEN1 (0.37) EDNRANPC1TP53RAB9AALDH1A1
SCHEMBL7967039 0.82 PTGS2 (0.37) KDM4ENPC1MAPK1RAB9ASMN1; SMN2
SCHEMBL7965515 0.82 PTGS2 (0.37) KDM4ENPC1MAPK1RAB9ASMN1; SMN2
SCHEMBL7966664 0.82 HCAR2 (0.46) ALDH1A1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL7030070 0.82 HCAR2 (0.46) ALDH1A1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL7969034 0.82 ALDH1A1 (0.38) KDM4EHPGDEDNRASMN1; SMN2ALDH1A1
SCHEMBL6927977 0.82 ALDH1A1 (0.38) KDM4EHPGDEDNRASMN1; SMN2ALDH1A1
SCHEMBL7593441 0.82 ALDH1A1 (0.38) KDM4EHPGDEDNRASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019029-B2 Skin whiteners containing hydroxytetronic acid derivatives THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, AS ADMINISTRATIVE AGENT 2006-03-28 US disclosed
US-20020141956-A1 Skin whiteners containing hydroxytetronic acid derivatives THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, AS ADMINISTRATIVE AGENT 2002-10-03 US disclosed
US-6265436-B1 ANTIINFLAMMATORY AGENTS OXIS THERAPEUTICS INC. 2001-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020141956-A1 Skin whiteners containing hydroxytetronic acid derivatives TYR, PPP6C, CYP26A1 KDM4E 3024/4885HPGD 202/4885ME2 2175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.